CLASS II ONGOING Device recall · Reported 17 Jun 2026 · FDA Enforcement Report

Mosaiq Oncology Information System recalled by Elekta

Elekta is recalling Mosaiq Oncology Information System, distributed nationwide in the US. The recall was initiated on 21 May 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSoftware Version: MOSAIQ 3.2/UDI: 07340201500071
Quantity recalled12 programs

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2406-2026
FDA event ID
98980
Recalling firm
Elekta, Atlanta, GA
Classification
Class II
Status
Ongoing
Recall initiated
21 May 2026
FDA classified
11 Jun 2026
Reported
17 Jun 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

21 May 2026Recall initiated by company
11 Jun 2026Classified by FDA+21 days
17 Jun 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Software may fail to load adapted baseline shift plan during treatment delivery when a communication error occurs.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

MOSAIQ Oncology Information System

Where it was distributed

Worldwide - US Nationwide distribution in the states of WI, FL, LA, NY, NY, NJ, KS, FL, IA, NM, TX and the countries of Bahrain, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, India, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Pakistan, Panama, Poland, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom.

Nationwide FloridaIowaKansasLouisianaNew JerseyNew MexicoNew YorkTexasWisconsin

Questions about this recall

Why was it recalled?

Software may fail to load adapted baseline shift plan during treatment delivery when a communication error occurs.

Which lots are affected?

Software Version: MOSAIQ 3.2/UDI: 07340201500071

Where was it sold?

Worldwide - US Nationwide distribution in the states of WI, FL, LA, NY, NY, NJ, KS, FL, IA, NM, TX and the countries of Bahrain, Belgium, Canada, China, Denmark, France, Germany, Hong Kong, India, Israel, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Pakistan, Panama, Poland, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, United Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Elekta

All 122

Other Medical Software recalls

All 932